Article History
Received: 1 February 2019
Accepted: 16 March 2019
First Online: 2 April 2019
Compliance with ethical standards
:
: M Oelke has received for OAB a speaker honorarium from Astellas, Duchesnay, Pierre Fabre and Pfizer, is advisory board member of Astellas and Pfizer, received research grants from Astellas and Pfizer, and participated in clinical trials from Apogepha, Astellas and Pfizer. M Addali has no conflict of interest. C Reisenauer has received a speaker honorarium from Astellas, Boston Scientific, Coloplast and Medtronic.
: This article does not contain any studies with human participants or animals performed by any of the authors.